MERIT – A phase II marker identification trial for TarcevaTM in second line NSCLC patients


Grant Data
Project Title
MERIT – A phase II marker identification trial for TarcevaTM in second line NSCLC patients
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Duration
27
Start Date
2005-07-06
Completion Date
2007-10-05
Amount
154641
Conference Title
Presentation Title
Keywords
MERIT
Discipline
Cancer
Sponsor
Other projects
Grant Type
F Hoffmann-La Roche and Co. Ltd. - General Award
Funding Year
2005/2006
Status
On-going